Armengol G, Tarkkanen M, Virolainen M, Forus A, Valle J, Böhling T, Asko-Seljavaara S, Blomqvist C, Elomaa I, Karaharju E, Kivioja A H, Siimes M A, Tukiainen E, Caballín M R, Myklebost O, Knuutila S
Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.
Br J Cancer. 1997;75(10):1403-9. doi: 10.1038/bjc.1997.242.
Comparative genomic hybridization (CGH) was used to detect copy number changes of DNA sequences in the Ewing family of tumours (ET). We analysed 20 samples from 17 patients. Fifteen tumours (75%) showed copy number changes. Gains of DNA sequences were much more frequent than losses, the majority of the gains affecting whole chromosomes or whole chromosome arms. Recurrent findings included copy number increases for chromosomes 8 (seven out of 20 samples; 35%), 1q (five samples; 25%) and 12 (five samples; 25%). The minimal common regions of these gains were the whole chromosomes 8 and 12, and 1q21-22. High-level amplifications affected 8q13-24, 1q and 1q21-22, each once. Southern blot analysis of the specimen with high-level amplification at 1q21-22 showed an amplification of FLG and SPRR3, both mapped to this region. All cases with a gain of chromosome 12 simultaneously showed a gain of chromosome 8. Comparison of CGH findings with cytogenetic analysis of the same tumours and previous cytogenetic reports of ET showed, in general, concordant results. In conclusion, our findings confirm that secondary changes, which may have prognostic significance in ET, are trisomy 8, trisomy 12 and a gain of DNA sequences in 1q.
采用比较基因组杂交(CGH)技术检测尤因肿瘤家族(ET)中DNA序列的拷贝数变化。我们分析了17例患者的20个样本。15个肿瘤(75%)显示出拷贝数变化。DNA序列的增加比减少更为常见,大多数增加影响整条染色体或整条染色体臂。常见的发现包括8号染色体(20个样本中有7个;35%)、1q(5个样本;25%)和12号染色体(5个样本;25%)的拷贝数增加。这些增加区域的最小共同区域是整条8号和12号染色体以及1q21 - 22。高水平扩增分别影响8q13 - 24、1q和1q21 - 22各一次。对1q21 - 22处有高水平扩增的样本进行Southern印迹分析,结果显示定位于该区域的FLG和SPRR3均有扩增。所有12号染色体增加的病例同时显示8号染色体增加。将CGH结果与同一肿瘤的细胞遗传学分析以及ET先前的细胞遗传学报告进行比较,总体结果一致。总之,我们的研究结果证实,在ET中可能具有预后意义的继发性改变是8号三体、12号三体以及1q处DNA序列的增加。